Novo Nordisk CEO: Hims' $49 compounded Wegovy pill a 'waste' of money
Hims(US:HIMS) Reuters·2026-02-05 16:38Novo Nordisk CEO Mike Doustdar was in a meeting with investors on Thursday discussing the company's tough recent outlook when one interrupted him with shock news: U.S. telehealth firm Hims and Hers He... ...